196 related articles for article (PubMed ID: 15634921)
21. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen.
Baharav E; Merimsky O; Altomonte M; Shoenfeld Y; Pavlovic M; Maio M; Ferrone S; Fishman P
Melanoma Res; 1995 Oct; 5(5):337-43. PubMed ID: 8541724
[TBL] [Abstract][Full Text] [Related]
22. Mimotope vaccines: epitope mimics induce anti-cancer antibodies.
Riemer AB; Jensen-Jarolim E
Immunol Lett; 2007 Oct; 113(1):1-5. PubMed ID: 17825923
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
Wang X; Luo W; Ferrone S
Medicina (B Aires); 2000; 60 Suppl 2():48-50. PubMed ID: 11188931
[TBL] [Abstract][Full Text] [Related]
24. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
25. Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
Hafner C; Wagner S; Jasinska J; Allwardt D; Scheiner O; Wolff K; Pehamberger H; Wiedermann U; Breiteneder H
J Invest Dermatol; 2005 Jan; 124(1):125-31. PubMed ID: 15654965
[TBL] [Abstract][Full Text] [Related]
26. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
Chen ZJ; Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768
[No Abstract] [Full Text] [Related]
28. Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Wang X; Matsumoto K; Ferrone S
Hybridoma; 1995 Apr; 14(2):175-81. PubMed ID: 7590776
[TBL] [Abstract][Full Text] [Related]
29. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
Kusama M; Kageshita T; Chen ZJ; Ferrone S
J Immunol; 1989 Dec; 143(11):3844-52. PubMed ID: 2584721
[TBL] [Abstract][Full Text] [Related]
30. Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.
Navari M; Zare M; Javanmardi M; Asadi-Ghalehni M; Modjtahedi H; Rasaee MJ
Immunopharmacol Immunotoxicol; 2014 Oct; 36(5):309-15. PubMed ID: 25070131
[TBL] [Abstract][Full Text] [Related]
31. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
[No Abstract] [Full Text] [Related]
32. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
Beenhouwer DO; May RJ; Valadon P; Scharff MD
J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
34. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.
Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X
Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529
[TBL] [Abstract][Full Text] [Related]
35. Immunogenically fit subunit vaccine components via epitope discovery from natural peptide libraries.
Matthews LJ; Davis R; Smith GP
J Immunol; 2002 Jul; 169(2):837-46. PubMed ID: 12097387
[TBL] [Abstract][Full Text] [Related]
36. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo.
Allen SD; Garrett JT; Rawale SV; Jones AL; Phillips G; Forni G; Morris JC; Oshima RG; Kaumaya PT
J Immunol; 2007 Jul; 179(1):472-82. PubMed ID: 17579068
[TBL] [Abstract][Full Text] [Related]
37. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.
Wierzbicki A; Gil M; Ciesielski M; Fenstermaker RA; Kaneko Y; Rokita H; Lau JT; Kozbor D
J Immunol; 2008 Nov; 181(9):6644-53. PubMed ID: 18941255
[TBL] [Abstract][Full Text] [Related]
38. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
39. An In vivo study: Adjuvant activity of poly-n-vinyl-2-pyrrolidone-co-acrylic acid on immune responses against Melanoma synthetic peptide.
Kızılbey K; Mansuroğlu B; Derman S; Mustafaeva Akdeste Z
Bioengineered; 2018 Jan; 9(1):134-143. PubMed ID: 28910565
[TBL] [Abstract][Full Text] [Related]
40. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]